Nanotechnology Detects Molecular Biomarker for Osteoarthritis
News Mar 13, 2018 | Original Story from Wake Forest Baptist Medical Center.
Adam Hall, assistant professor of biomedical engineering at Wake Forest School of Medicine, injects microliters of fluid into a flow cell holding a nanopore device that has demonstrated the ability to detect molecular biomarkers of disease. Credit: Wake Forest Baptist Medical Center Photography.
For the first time, scientists at Wake Forest Baptist Medical Center have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology.
This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid (HA).
HA is a naturally occurring molecule that is involved in tissue hydration, inflammation and joint lubrication in the body. The abundance and size distribution of HA in biological fluids is recognized as an indicator of inflammation, leading to osteoarthritis and other chronic inflammatory diseases. It can also serve as an indicator of how far the disease has progressed.
“Our results established a new, quantitative method for the assessment of a significant molecular biomarker that bridges a gap in the conventional technology,” said lead author Adam R. Hall, Ph.D., assistant professor of biomedical engineering at Wake Forest School of Medicine, part of Wake Forest Baptist.
“The sensitivity, speed and small sample requirements of this approach make it attractive as the basis for a powerful analytic tool with distinct advantages over current assessment technologies.”
The most widely used method is gel electrophoresis, which is slow, messy, semi-quantitative, and requires a lot of starting material, Hall said. Other technologies include mass spectrometry and size-exclusion chromatography, which are expensive and limited in range, and multi-angle light scattering, which is non-quantitative and has limited precision.
The study, which is published in the current issue of Nature Communications, was led by Hall and Elaheh Rahbar, Ph.D., of Wake Forest Baptist, and conducted in collaboration with scientists at Cornell University and the University of Oklahoma.
In the study, Hall, Rahbar and their team first employed synthetic HA polymers to validate the measurement approach. They then used the platform to determine the size distribution of as little as 10 nanograms (one-billionth of a gram) of HA extracted from the synovial fluid of a horse model of osteoarthritis.
The measurement approach consists of a microchip with a single hole or pore in it that is a few nanometers wide – about 5,000 times smaller than a human hair. This is small enough that only individual molecules can pass through the opening, and as they do, each can be detected and analyzed. By applying the approach to HA molecules, the researchers were able to determine their size one-by-one. HA size distribution changes over time in osteoarthritis, so this technology could help better assess disease progression, Hall said.
“By using a minimally invasive procedure to extract a tiny amount of fluid – in this case synovial fluid from the knee – we may be able to identify the disease or determine how far it has progressed, which is valuable information for doctors in determining appropriate treatments,” he said.
Hall, Rahbar and their team hope to conduct their next study in humans, and then extend the technology with other diseases where HA and similar molecules play a role, including traumatic injuries and cancer.
This article has been republished from materials provided by Wake Forest Baptist Medical Center. Note: material may have been edited for length and content. For further information, please contact the cited source.
Felipe Rivas, Osama K. Zahid, Heidi L. Reesink, Bridgette T. Peal, Alan J. Nixon, Paul L. DeAngelis, Aleksander Skardal, Elaheh Rahbar, Adam R. Hall. Label-free analysis of physiological hyaluronan size distribution with a solid-state nanopore sensor. Nature Communications, 2018; 9 (1) DOI: 10.1038/s41467-018-03439-x.
SMi’s 5th Annual Molecular Diagnostics Conference 2018 Agenda ReleasedNews
SMi proudly presents its 5th annual conference on Molecular Diagnostics, taking place at the Holiday Inn Kensington Forum, London, UK on 9th and 10th July 2018, with a half-day post-conference workshops on 11th July 2018.READ MORE
Bacteria Eats Greenhouse Gas with a Side of ProteinNews
With the ability to leech heavy metals from the environment and digest a potent greenhouse gas, methanotrophic bacteria pull double duty when it comes to cleaning up the environment. Scientists have identified two never-before-studied proteins, MbnB and MbnC, as partially responsible for the bacteria’s capabilities.READ MORE
Microgel Mops Up Toxins Without Harming "Good" BacteriaNews
While it’s easy to blame the bacteria during intestinal infections, it’s actually the toxins the bacteria produce that trigger inflammation, diarrhea, fever and cramps. Treatments typically include indiscriminate antibiotics that slaughter health-promoting gut bacteria along with disease-causing microbes. Researchers now report the development of a microgel scavenger that targets toxins instead of bacteria.READ MORE